Publications by authors named "Patrick Blatchford"

Article Synopsis
  • * The study involved 50 patients who had not responded to at least two previous treatments, resulting in an objective response rate (ORR) of 12%, which was statistically better than historical data.
  • * While the combination treatment showed a high disease control rate and acceptable side effects, it did not achieve the primary goal of improving ORR compared to historical controls.
View Article and Find Full Text PDF
Article Synopsis
  • Cabozantinib, a multi-tyrosine kinase inhibitor (TKI), showed promising efficacy in treating metastatic colorectal cancer (mCRC), outperforming regorafenib in preclinical studies.
  • A phase II clinical trial with 44 patients assessed its effectiveness, revealing that 45% experienced progression-free survival (PFS) after 12 weeks, with a median overall survival of 8.3 months.
  • Despite some serious adverse events reported, the study concluded that cabozantinib could be a viable treatment option for mCRC patients who have exhausted other therapies, warranting further research.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists found that a medicine called cabozantinib can help a type of cancer called MSS-CRC work better with another medicine, nivolumab, which usually only helps a different type, MSI-high CRC.
  • They tested this combination on special mice with human immune systems and saw that it made the tumors grow slower in most of their experiments.
  • The study suggests that this combination might be worth trying in real-life tests with cancer patients who have MSS-CRC to see if it helps them too!
View Article and Find Full Text PDF

The consistency of reporting results for patient-derived xenograft (PDX) studies is an area of concern. The PDX method commonly starts by implanting a derivative of a human tumor into a mouse, then comparing the tumor growth under different treatment conditions. Currently, a wide array of statistical methods (e.

View Article and Find Full Text PDF

Background: Endurance exercise can cause a decrease in serum ionized calcium (iCa) and increases in parathyroid hormone (PTH) and bone resorption, reflected by serum carboxy-terminal collagen crosslinks (CTX). We developed a calcium clamp to prevent the decrease in iCa during exercise, which attenuated increases in PTH and CTX during vigorous cycling in young men. The goal was to determine whether this occurs in older adults during brisk walking.

View Article and Find Full Text PDF

Over the past decade, immunotherapies have revolutionized the treatment of cancer. Although the success of immunotherapy is remarkable, it is still limited to a subset of patients. More than 1500 clinical trials are currently ongoing with a goal of improving the efficacy of immunotherapy through co-administration of other agents.

View Article and Find Full Text PDF

Although all clinical trials are designed and monitored using more than one endpoint, methods are needed to assure that decision criteria are chosen to reflect the clinically relevant tradeoffs that assure the trial's scientific integrity. This article presents a framework for the design and monitoring clinical trials in a bivariate outcome space. The framework uses a rectangular hyperbola to define a bivariate null curve that divides outcome space into regions of benefit and lack of benefit.

View Article and Find Full Text PDF

Background: Interventions targeting psychosocial factors may improve rehabilitation outcomes for prosthesis users after lower-limb amputation (LLA), but there is a need to identify targeted factors for minimizing disability.

Objective: To identify psychosocial factors related to disability for prosthesis users after LLA in middle age or later.

Design: Cross-sectional study.

View Article and Find Full Text PDF

Endothelial function declines progressively across stages of the menopause transition; however, the mechanisms contributing to this decline are unknown. We hypothesized that differences in endothelial function among pre-, peri, and postmenopausal women are related to differences in estradiol and oxidative stress. Brachial artery flow-mediated dilation (FMD) was measured in 87 healthy women categorized by menopause stage (24 premenopausal, 17 early and 21 late perimenopausal, and 25 postmenopausal) before and after 3 days of ovarian hormone suppression (gonadotropin releasing hormone antagonist [GnRH]) alone, and an additional 3 days of GnRH with concurrent transdermal estradiol or placebo add-back treatment.

View Article and Find Full Text PDF

Purpose: Colorectal cancer (CRC) is the third most common cancer in the USA. The objective of this study was to compare quality of life (QoL) across long-term colorectal cancer survivors and unaffected matched controls while adjusting for comorbidities.

Methods: The National Cancer Institute (NCI)-funded Colon Cancer Family Registry (CCFR) was used to randomly select and recruit CRC survivors (≥ 5 years from diagnosis) and matched controls for a cross-sectional survey.

View Article and Find Full Text PDF

Background: Lower-limb amputation (LLA) due to non-traumatic vascular etiology is linked to extremely low physical activity and high disability.

Objective: To test the feasibility of a biobehavioral intervention designed to promote physical activity.

Design: A randomized, single-blind feasibility trial with a crossover design.

View Article and Find Full Text PDF

Regular exercise enhances endothelial function in older men, but not consistently in estrogen-deficient postmenopausal women. Estradiol treatment improves basal endothelial function and restores improvements in endothelial function (flow-mediated dilation, FMD) to aerobic exercise training in postmenopausal women; however, estradiol treatment is controversial. Resveratrol, an estrogen receptor ligand, enhances exercise training effects on cardiovascular function and nitric oxide (NO) release in animal models, but impairs exercise training effects in men.

View Article and Find Full Text PDF

Background: The same trauma that produces concussion may also produce neck injury. The signs of concussion and neck injury are similar, and symptoms after acceleration-deceleration trauma to the head-neck complex do not accurately discriminate between them. Research on the epidemiology of neck injury among sport-concussed youth is sparse.

View Article and Find Full Text PDF

Lung cancer chemoprevention, especially in high-risk former smokers, has great potential to reduce lung cancer incidence and mortality. Thiazolidinediones prevent lung cancer in preclinical studies, and diabetics receiving thiazolidinediones have lower lung cancer rates which led to our double-blind, randomized, phase II placebo-controlled trial of oral pioglitazone in high-risk current or former smokers with sputum cytologic atypia or known endobronchial dysplasia. Bronchoscopy was performed at study entry and after completing 6 months of treatment.

View Article and Find Full Text PDF

Background: Physical activity remains low and nearly unchanged from preoperative levels following total knee arthroplasty (TKA), and this is thought to underlie long-term functional limitations, secondary health problems, and higher health care costs after TKA.

Objective: Our objective is to determine whether a telehealth-based intervention could improve physical activity and functional outcomes after TKA.

Design: The design is a 2-arm, parallel, assessor-blinded, randomized controlled trial with baseline, midintervention, postintervention, and 6-month follow-up assessments.

View Article and Find Full Text PDF

The cardiovascular effects of testosterone (T) are controversial. Low T has been associated with accelerated vascular aging, characterized by large elastic artery stiffening (decreased compliance), intimal-medial thickening (IMT), and endothelial dysfunction. Endurance exercise improves vascular function, but resistance training may increase arterial stiffness.

View Article and Find Full Text PDF

Our goal was to evaluate the safety and toxicity of combining a PARP inhibitor, olaparib, with cetuximab and fractionated intensity-modulated radiotherapy for patients with locally advanced head and neck cancer and heavy smoking histories. Patients with ≥10 packs/year history of smoking were treated with olaparib at doses ranging from 25-200 mg orally twice daily beginning approximately 10 days prior to initiation of and with concurrent radiation (69.3 Gy in 33 fractions) using a time-to-event continual reassessment method model.

View Article and Find Full Text PDF

Antiangiogenic therapy used in treatment of metastatic colorectal cancer (mCRC) inevitably succumbs to treatment resistance. Upregulation of MET may play an essential role to acquired anti-VEGF resistance. We previously reported that cabozantinib (XL184), an inhibitor of receptor tyrosine kinases (RTK) including MET, AXL, and VEGFR2, had potent antitumor effects in mCRC patient-derived tumor explant models.

View Article and Find Full Text PDF

Objective: The menopausal transition is associated with somatic symptoms and increased rates of depression, which can impair quality of life (QOL) and increase cardiovascular disease (CVD) risk. This period is also associated with accelerated vascular aging (arterial stiffening and endothelial dysfunction), an antecedent to CVD. This secondary analysis sought to explore associations between depression, menopausal symptoms and QOL, and vascular aging across menopause stages.

View Article and Find Full Text PDF

Irinotecan, a standard of care therapy for CRC, elicits cytotoxic effects by generating double strand breaks resulting in DNA damage. The activation of the ATM pathway plays a fundamental role in regulating the cellular response and repair to DNA damage. The objective of this preclinical study was to determine whether ATM inhibition would enhance sensitivity to irinotecan treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Desmoid fibromatosis is a type of tumor linked to mutations in the WNT pathway, and a study was conducted to evaluate the oral gamma secretase inhibitor PF-03084014 for treatment.
  • In a small cohort of seven patients, 71.4% achieved a partial response to the treatment, with most maintaining their response for extended periods even after stopping the medication.
  • The study concluded that PF-03084014 is effective and well-tolerated, showing significant disease control, particularly at lower doses.
View Article and Find Full Text PDF

Objectives: To enhance understanding of the relationship between multimorbidity, symptom burden, and functional status in individuals with life-limiting illness.

Design: Secondary analysis of baseline data from a randomized clinical trial conducted in the Palliative Care Research Cooperative Group. Group differences were tested using a t-test; multivariate regression analysis was used to determine the effect of multiple variables on functional status and symptom burden.

View Article and Find Full Text PDF

Objectives: Among patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy, recent retrospective and prospective data have suggested improved outcomes with altered fractionation over conventional fractionation (CFxn). We sought to characterize national fractionation patterns and to compare outcomes among them.

Materials And Methods: We queried the National Cancer Database for T2N0M0 squamous cell carcinomas of the glottis diagnosed from 2004-2014 and managed with definitive radiotherapy.

View Article and Find Full Text PDF